5 pharma/healthcare IPOs to raise over Rs 8,000 cr this month

5 pharma/healthcare IPOs to raise over Rs 8,000 cr this month

Riding on huge investor interest in the healthcare sector, five pharma companies are tapping the initial public offering (IPO) market over the next couple of weeks to raise over Rs 8,000 crore.
The list include the Rs 4,000-crore IPO by the Bain Capital-backed Emcure Pharma, the Rs 1,500-crore issue by Vijaya Diagnostic Centre, diagnostic firms Krsnaa Diagnostics (Rs 1,200 crore) and Mumbai-based bulk drugs maker Supriya Lifesciences (Rs 1,200 crore), and pharma formulations contract development and manufacturer (CDMO) Windlass Biotech’s Rs 400 crore issue.
Investment bankers estimate these five companies to together raise over Rs 8,300 crore through the public offerings this month.
According to data available with the stock exchanges, so far this fiscal, 12 firms have raised Rs 27,000 crore from IPOs, and Rs 70,000-crore more issues are in the pipeline. The entire FY21 saw only 30 IPOs raising Rs 31,277 crore.
Apart from these pharma firms, Devyani International and and Exxaro Til
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

Electronic Organizer, BAGSMART Accessories Organizer Travel Double Layer Electronics Bag Large for 10.5 inch iPad Pro, Adapter, Cables, Black

Price: (as of – Details) From the brand BAGSMART Electronic Organizer Electronic Organizer for Women BAGSMART Electronic Organizer About BAGSMART: A Bagsmart product is the perfect companion for the nomadic urban lifestyle. It is all about mobility and resilience and enables its user to be prepared for all eventualities of modern life. The product allows […]

Local lead plan – Local lead generation training course

Product Name: Local lead plan – Local lead generation training course Click here to get Local lead plan – Local lead generation training course at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Local lead plan – Local lead […]

Investors saw Mailchimp’s demise. It sold for $12 bn

Investors saw Mailchimp’s demise. It sold for $12 bn

In the early days of building his email-marketing startup Mailchimp, Ben Chestnut was warned by venture capitalists about the company’s imminent demise should he not take their money and advice.“A lot would give me the same pitch from the last guy, always a semi-threatening pitch,” Chestnut said in a Zoom call. “Like an insurance salesmen:…